These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38022600)

  • 21. Estimation of Antibody-Verified Eplet Mismatch Load, 2-Field HLA Resolution vs Imputation in a Large Cohort of European Donors.
    Renuncio-García M; González-López E; Carreras E; Villa J; Romón-Alonso I; Roa-Bautista A; Gutiérrez-Larrañaga M; Comins-Boo A; Irure-Ventura J; López-Hoyos M; San Segundo D
    Transplant Proc; 2022 Nov; 54(9):2414-2418. PubMed ID: 36333253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies.
    Duquesnoy RJ; Marrari M; Mulder A; Claas FH; Mostecki J; Balazs I
    Hum Immunol; 2012 Mar; 73(3):267-77. PubMed ID: 22227099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eplet incompatibility in pediatric renal transplantation.
    Rãchişan AL; Dubois V; Ranchin B; Sellier-Leclerc AL; Bertholet Thomas A; Cochat P; Bacchetta J
    Pediatr Transplant; 2020 Sep; 24(6):e13721. PubMed ID: 32388894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA antigen sharing between mother and fetus as a risk factor for eclampsia and preeclampsia.
    Biggar RJ; Poulsen G; Ng J; Melbye M; Boyd HA
    Hum Immunol; 2010 Mar; 71(3):263-7. PubMed ID: 20074602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal human leukocyte antigen-C and maternal killer-cell immunoglobulin-like receptors in cases of severe preeclampsia.
    Larsen TG; Hackmon R; Geraghty DE; Hviid TVF
    Placenta; 2019 Jan; 75():27-33. PubMed ID: 30712663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an immunogenicity score for HLA-DQ eplets: A conceptual study.
    Schawalder L; Hönger G; Kleiser M; van Heck MR; van de Pasch LAL; Vendelbosch S; Rozemuller EH; Schaub S
    HLA; 2021 Jan; 97(1):30-43. PubMed ID: 33068062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.
    Bezstarosti S; Bakker KH; Kramer CSM; de Fijter JW; Reinders MEJ; Mulder A; Claas FHJ; Heidt S
    Front Immunol; 2021; 12():800946. PubMed ID: 35154076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet transfusions in haploidentical haematopoietic stem cell allograft candidates: Protecting HLA-A and HLA-B antigens through eplet analysis.
    Durand G; Desoutter J; Lorriaux C; Poumaredes G; Joris M; Charbonnier A; Lebon D; Paubelle E; Garcon L; Guillaume N
    HLA; 2024 Mar; 103(3):e15438. PubMed ID: 38516935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity.
    Duquesnoy RJ
    Int J Immunogenet; 2012 Feb; 39(1):1-9. PubMed ID: 21981757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP.
    Duquesnoy RJ; Askar M
    Hum Immunol; 2007 Jan; 68(1):12-25. PubMed ID: 17207708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory placental lesions are specifically observed in healthy oocyte donation pregnancies with extreme fetal-maternal incompatibility.
    Tian X; Goemaere NNT; van der Meeren L; Yang J; Kapsenberg JM; Lashley LEELO; Eikmans M; van der Hoorn MP
    Placenta; 2023 Nov; 143():100-109. PubMed ID: 37866320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
    Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
    Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients.
    Charnaya O; Jones J; Philogene MC; Chiang PY; Segev DL; Massie AB; Garonzik-Wang J
    Pediatr Nephrol; 2021 Dec; 36(12):3971-3979. PubMed ID: 34100108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DR and -DQ eplet mismatches and transplant glomerulopathy: a nested case-control study.
    Sapir-Pichhadze R; Tinckam K; Quach K; Logan AG; Laupacis A; John R; Beyene J; Kim SJ
    Am J Transplant; 2015 Jan; 15(1):137-48. PubMed ID: 25521856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different eplet software programs give discordant and incorrect results: An analysis of HLAMatchmaker vs Fusion Matchmaker Eplet calling software.
    Tassone G; De Santis D; Vukovic I; Downing J; Martinez OP; D'Orsogna LJ
    HLA; 2020 Jul; 96(1):52-63. PubMed ID: 32281731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
    Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
    Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncomplicated oocyte donation pregnancies display an elevated CD163-positive type 2 macrophage load in the decidua, which is associated with fetal-maternal HLA mismatches.
    Tian X; Aiyer KTS; Kapsenberg JM; Roelen DL; van der Hoorn ML; Eikmans M
    Am J Reprod Immunol; 2022 Jan; 87(1):e13511. PubMed ID: 34738274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of preeclampsia.
    Dekker GA
    Pregnancy Hypertens; 2014 Jul; 4(3):246-7. PubMed ID: 26104648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
    Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.
    Sullivan PM; Warner P; Kemna MS; Albers EL; Law SP; Weiss NS; Law YM
    J Heart Lung Transplant; 2015 Jul; 34(7):950-7. PubMed ID: 25727771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.